Literature DB >> 15797510

Immune subversion by Helicobacter pylori.

Cosima T Baldari1, Antonio Lanzavecchia, John L Telford.   

Abstract

To maintain prolonged colonization of the human gastric mucosa, Helicobacter pylori must avoid both innate and adaptive immune responses. During its long coexistence with humans, it has evolved complex strategies to maintain a mild inflammation of the gastric epithelium while limiting the extent of immune effector activity. Severe disease, associated with bacterial colonization, might reflect loss of this control. Several mechanisms and the bacterial factors involved in immune subversion have, in recent years, been elucidated, thus opening the possibility of a better understanding of the pathogenicity of this microorganism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15797510     DOI: 10.1016/j.it.2005.01.007

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  28 in total

1.  Crystallization and preliminary crystallographic studies of Helicobacter pylori arginase.

Authors:  Jinyong Zhang; Xiaoli Zhang; Xuhu Mao; Quanming Zou; Defeng Li
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-05-26

2.  Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa.

Authors:  Antonia Pellicanò; Ladislava Sebkova; Giovanni Monteleone; Giovanni Guarnieri; Maria Imeneo; Francesco Pallone; Francesco Luzza
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

3.  Helicobacter pylori-induced interleukin-12 p40 expression.

Authors:  Eriko Takeshima; Koh Tomimori; Hiromitsu Teruya; Chie Ishikawa; Masachika Senba; Daniele D'Ambrosio; Fukunori Kinjo; Hitomi Mimuro; Chihiro Sasakawa; Toshiya Hirayama; Jiro Fujita; Naoki Mori
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

4.  Modelling the interaction between the host immune response, bacterial dynamics and inflammatory damage in comparison with immunomodulation and vaccination experiments.

Authors:  Angela M Jarrett; N G Cogan; M E Shirtliff
Journal:  Math Med Biol       Date:  2014-05-08       Impact factor: 1.854

5.  Helicobacter pylori vs coronary heart disease - searching for connections.

Authors:  Magdalena Chmiela; Adrian Gajewski; Karolina Rudnicka
Journal:  World J Cardiol       Date:  2015-04-26

Review 6.  Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.

Authors:  Richard J Bende; Febe van Maldegem; Carel J M van Noesel
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

Review 7.  Chinese Helicobacter pylori vaccine: Solution for an old challenge?

Authors:  Amin Talebi Bezmin Abadi; Yeong Yeh Lee
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

Review 8.  Regulation of vacuolar pH and its modulation by some microbial species.

Authors:  Kassidy K Huynh; Sergio Grinstein
Journal:  Microbiol Mol Biol Rev       Date:  2007-09       Impact factor: 11.056

9.  Helicobacter pylori: bacterial factors and the role of cytokines in the immune response.

Authors:  Tania Beatriz Romero-Adrián; Jorymar Leal-Montiel; Francisca Monsalve-Castillo; Edgardo Mengual-Moreno; Ernesto García McGregor; Lenis Perini; Ana Antúnez
Journal:  Curr Microbiol       Date:  2009-10-22       Impact factor: 2.188

10.  Anti-Helicobacter pylori activity and immunostimulatory effect of extracts from Byrsonima crassa Nied. (Malpighiaceae).

Authors:  Cibele Bonacorsi; Maria Stella G Raddi; Iracilda Z Carlos; Miriam Sannomiya; Wagner Vilegas
Journal:  BMC Complement Altern Med       Date:  2009-01-16       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.